Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP931356.RAZoPBog47nlFihjxCfXZCfFs-Cq-FUraK_bpPRSjlb6g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP931356.RAZoPBog47nlFihjxCfXZCfFs-Cq-FUraK_bpPRSjlb6g130_assertion type Assertion NP931356.RAZoPBog47nlFihjxCfXZCfFs-Cq-FUraK_bpPRSjlb6g130_head.
- NP931356.RAZoPBog47nlFihjxCfXZCfFs-Cq-FUraK_bpPRSjlb6g130_assertion description "[For patients with no evidence of disease and a follow-up of at least 5 years, the mean percent MIB-1 value was significantly lower than for those patients who were alive with local recurrence and/or metastasis or who had died from their adenoid cystic carcinoma (p =.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931356.RAZoPBog47nlFihjxCfXZCfFs-Cq-FUraK_bpPRSjlb6g130_provenance.
- NP931356.RAZoPBog47nlFihjxCfXZCfFs-Cq-FUraK_bpPRSjlb6g130_assertion evidence source_evidence_literature NP931356.RAZoPBog47nlFihjxCfXZCfFs-Cq-FUraK_bpPRSjlb6g130_provenance.
- NP931356.RAZoPBog47nlFihjxCfXZCfFs-Cq-FUraK_bpPRSjlb6g130_assertion SIO_000772 10897109 NP931356.RAZoPBog47nlFihjxCfXZCfFs-Cq-FUraK_bpPRSjlb6g130_provenance.
- NP931356.RAZoPBog47nlFihjxCfXZCfFs-Cq-FUraK_bpPRSjlb6g130_assertion wasDerivedFrom befree-20150227 NP931356.RAZoPBog47nlFihjxCfXZCfFs-Cq-FUraK_bpPRSjlb6g130_provenance.
- NP931356.RAZoPBog47nlFihjxCfXZCfFs-Cq-FUraK_bpPRSjlb6g130_assertion wasGeneratedBy ECO_0000203 NP931356.RAZoPBog47nlFihjxCfXZCfFs-Cq-FUraK_bpPRSjlb6g130_provenance.